CA
IMA

CHI Advisors’s ImageneBio Inc IMA Stock Holding History

CHI Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$9.44M Buy
181,745
+4,908
+3% +$296K 3.74% 8
2023
Q2 		$13.9M Buy
176,837
+38,431
+28% +$2.76M 4.22% 7
2023
Q1 		$5.73M Buy
138,406
+1,958
+1% +$90K 1.52% 12
2022
Q4 		$4.36M Buy
136,448
+35,256
+35% +$1.13M 1.16% 12
2022
Q3 		$4.31M Buy
101,192
+10,281
+11% +$594K 1.16% 15
2022
Q2 		$4.83M Buy
90,911
+23,015
+34% +$1.27M 1.85% 10
2022
Q1 		$4.97M Hold
67,896
– – 2.11% 11
2021
Q4 		$10.2M Buy
67,896
+41,646
+159% +$6.75M 3.39% 9
2021
Q3 		$3.98M Sell
26,250
-41,646
-61% -$6.05M 1.16% 14
2021
Q2 		$11.4M Hold
67,896
– – 2.66% 10
2021
Q1 		$23M Buy
+67,896
New +$23.3M 4.61% 8

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors's IMA Position: Q3 2023 in Review

CHI Advisors increased its ImageneBio Inc (IMA) stake by 2.8% in Q3 2023, buying an estimated $296K and bringing the position to 181,745 shares worth $9.44M. The position accounts for 3.74% of the portfolio, ranked #8.

CHI Advisors first reported a position in IMA in Q1 2021 and has held it in 11 quarters since. The position peaked at $23M in Q1 2021. 58 funds tracked by Wall St. Rank hold IMA as of Q3 2023.

  • CHI Advisors held 181,745 shares of ImageneBio Inc worth $9.44M as of Q3 2023.
  • CHI Advisors bought 4,908 ImageneBio Inc shares in Q3 2023, an estimated $296K.
  • ImageneBio Inc made up 3.74% of CHI Advisors's portfolio in Q3 2023, its #8 holding.
  • CHI Advisors first reported a position in ImageneBio Inc in Q1 2021 and has held it in 11 quarters since.
  • CHI Advisors's ImageneBio Inc position peaked at $23M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.